Statistically significant increases in age-adjusted mortality rates of all cancer and some specific types of cancer, namely, ovarian cancer, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancers, were observed in 2022 after two-thirds of the Japan population had received the third or later dose of SARS-CoV-2 mRNA-LNP vaccine. These particularly marked […]

//